“Cancer”的搜索结果，显示 111-120 项，共有 10805 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. ... Cancer” ( ...

2. Noninvasive radiologic biomarkers to individualize lung cancer therapy - 妙佑医疗国际

   Noninvasive radiologic biomarkers to individualize lung cancer therapy · 一份馈赠，无穷力量——今天就来伸出援手！ · 关于妙佑医疗国际 · 医疗专业人员专区 · 商务专区.

3. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - 妙佑医疗国际

   医疗专业人员 · Advances in lung cancer immunotherapy and management of immune-mediated adverse events · 一份馈赠，无穷力量——今天就来伸出援手！ · 关于妙佑医疗国际.

4. 神经科 - 临床试验 - 妙佑医疗国际

   ... cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER and PR) all ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   HER2 is found on some cancer cells. When pertuzumab or trastuzumab attach to HER2, the signals that tell the cells to grow are blocked and the tumor cell may be ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... cancer and high gene risk score. Abiraterone acetate may help fight prostate cancer by lowering the amount of testosterone made by the body. Apalutamide may ...

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. ... Cancer” ( ...

8. Adrenocortical cancer presenting as postmenopausal bleeding A case from the endocrine teaching clinics - 妙佑医疗国际

   Adrenocortical cancer presenting as postmenopausal bleeding A case from the endocrine teaching clinics · 一份馈赠，无穷力量——今天就来伸出援手！ · 关于妙佑医疗国际.

9. 神经科 - 临床试验 - 妙佑医疗国际

   ... cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER and PR) all ...

10. 神经科 - 临床试验 - 妙佑医疗国际

    ... cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER and PR) all ...